Interferon in relapsing-remitting multiple sclerosis-Reference-Cited by-同舟云学术

Interferon in relapsing-remitting multiple sclerosis

Published:2001-10-23 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Rice George PA¹,Incorvaia Barbara²,Munari Luca M.³,Ebers George⁴,Polman Chris⁵,D'Amico Roberto⁶,Parmelli Elena⁶,Filippini Graziella⁷

Affiliation:

1. University of Western Ontario; Clinical Neurological Sciences; 339 Windermere Road London Ontario Canada N6A 5A5

2. Osservatorio Epidemiologico - Regione Umbria; Cochrane Neurological Network; Via M. Angeloni, 61 Perugia Italy 06124

3. Azienda Ospedaliera Ospedale Niguarda Ca' Granda; P.zza Ospedale Maggiore, 3 Milan Italy 20162

4. University of Oxford; Clinical Neurology; 3rd Floor - West Wing John Radcliffe Hospital Oxford UK OX3 9DU

5. VU Medical Centre; Neurology; De Boelelaan 1117 - P.O. Box 7057 Amsterdam Netherlands 1007

6. University of Modena and Reggio Emilia; Department of Oncology and Hematology; Via del Pozzo 71 Modena Italy

7. Fondazione I.R.C.C.S. - Istituto Neurologico C.Besta; Neuroepidemiology Unit; via Celoria 11 Milano Italy 20133

Publisher

Wiley

Subject

Pharmacology (medical)

Reference76 articles.

1. Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis;Bongioanni;Journal of the Neurological Sciences,1996

2. Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis;Durelli;Neurology,1994

3. Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: disease activity resumes after stopping treatment;Durelli;Neurology,1996

4. Interferon (IFN)-Alpha 2a treatment of relapsing-remitting (R/R) multiple sclerosis (MS): disease activity resumes after stopping treatment [Abstract];Durelli;Neurology,1994

5. Interferon beta in multiple sclerosis [Editorial];Arnason;Neurology,1993

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms;Life;2022-05-05

2. Multiple sclerosis in Peru: National prevalence study using capture-recapture analysis;Multiple Sclerosis and Related Disorders;2021-10

3. Alternative Activation of Macrophages through Interleukin-13-Loaded Extra-Large-Pore Mesoporous Silica Nanoparticles Suppresses Experimental Autoimmune Encephalomyelitis;ACS Biomaterials Science & Engineering;2021-08-26

4. Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery;Frontiers in Pharmacology;2021-05-04

5. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome;Cochrane Database of Systematic Reviews;2020-01-25